Results 61 to 70 of about 10,088 (191)

Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review

open access: yesTherapeutic Advances in Gastroenterology, 2020
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with a multifactorial pathophysiology. The gut microbiota differs between patients with IBS and healthy individuals.
William D. Chey   +2 more
doaj   +1 more source

Association of Aspirin With Improved Clinical Outcomes and Survival in Patients With Compensated Cirrhosis: A Propensity Score‐Matched Study of 25 782 Individuals

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Pharmacologic therapies to prevent decompensation in cirrhosis remain limited. Aim To evaluate the association between aspirin use and cirrhosis‐related outcomes and mortality. Methods This retrospective cohort study utilized deidentified electronic health records from a global federated network (January 2013–July 2025). Adults with
Shahem Abbarh   +6 more
wiley   +1 more source

Rifaximin Protects Against Inflammation and Fibrosis in MASH: Any Role for Ethanol-Producing Bacteria?

open access: yesPathogens
Metabolic Dysfunction-Associated Steato-Hepatitis (MASH) is a multiple-hit disease. Endotoxins, ethanol, and other metabolites of certain gut microbiota can reach the liver and accelerate inflammation and disease progression.
Mohamed Abouelkheir   +2 more
doaj   +1 more source

Recent Development of Endo‐hepatology

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Endo‐hepatology is a rapidly evolving field encompassing endoscopic diagnosis and treatment of hepatobiliary diseases, primarily using endoscopic ultrasound (EUS). Since its conceptualization in 2012, the field has expanded dramatically alongside advances in interventional EUS. A landmark 2024 review broadened the concept to include endoscopic
Akira Yamamiya   +3 more
wiley   +1 more source

Rifaximin has the potential to prevent complications of cirrhosis

open access: yesTherapeutic Advances in Gastroenterology, 2018
Background: Cirrhosis-related complications are associated with poor prognosis. With our analyses, we examined the potential benefit of rifaximin in reducing the risk of developing cirrhosis-related complications.
Steven L. Flamm   +3 more
doaj   +1 more source

Fecal Microbiota Transplantation: A Promising Therapeutic Strategy Targeting the Microbiota–Gut–Brain Axis in Anorexia Nervosa

open access: yesBrain and Behavior, Volume 16, Issue 11, November 2026.
Gut dysbiosis in anorexia nervosa may impair microbiota–gut–brain signaling through metabolic, immune, and vagal pathways. Fecal microbiota transplantation is being investigated as a potential strategy to restore host–microbiome balance, support a healthier microbial composition, and improve gastrointestinal function, appetite, and mood.
Shawn L. Kwok   +2 more
wiley   +1 more source

Dual‐Spectrum Fluorescence Quenching of Aggregation‐Induced Emission Nanoparticles for Dual‐Signal Lateral Flow Immunoassay of Danofloxacin in Meat Samples

open access: yesFood Frontiers, Volume 7, Issue 6, November 2026.
ABSTRACT The conventional gold nanoparticle‐based lateral flow immunoassay (AuNPs‐LFIA) is hampered by single colorimetric signal readout and insufficient sensitivity, restricting its broad application in trace detection for food safety. Herein, an AuNPs‐triggered dual‐spectrum fluorescence quenching LFIA (DSFQ‐LFIA) was constructed for colorimetric ...
Meng Jia   +6 more
wiley   +1 more source

Correlation networks before and after rifaximin.

open access: yes, 2013
Legend common for figures 4A, 4B and 4C: The complex correlation network represented parameters that were linked with a correlation coefficient >0.6 (negative or positive) and with a p value 0.6 or
Phillip B. Hylemon (253333)   +15 more
core   +1 more source

Rifaximin-Induced Rhabdomyolysis. [PDF]

open access: yesCureus
Rifaximin is a non-absorbable oral antibiotic widely used for the management of traveler's diarrhea, hepatic encephalopathy, and irritable bowel syndrome diarrhea type. Although rifaximin is generally tolerated, rare cases of rhabdomyolysis have been reported, particularly in patients with cirrhosis with and without statin therapy.
Acheampong S   +3 more
europepmc   +4 more sources

Alcohol‐Associated Liver Disease: Epidemiology, Pathogenesis, and Emerging Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 11, November 2026.
ALD imposes a growing global burden influenced by alcohol consumption, genetic susceptibility, and obesity. Its pathogenesis involves interactions among ethanol metabolism, oxidative stress, innate immune activation, regulated cell death, and disruption of the gut–liver axis.
Shuyan Wang, Yirui Hu, Huikuan Chu
wiley   +1 more source

Home - About - Disclaimer - Privacy